20
Participants
Start Date
November 30, 2017
Primary Completion Date
July 2, 2020
Study Completion Date
July 2, 2020
BMS-986205
specified dose on specified day
Nivolumab
Specified dose on specified day
Placebo
Specified dose on specified day
Local Institution, Dublin
Local Institution, Dublin
Melanoma Institute Australia, North Sydney
Local Institution, Blacktown
Local Institution, Melbourne
Local Institution, Melbourne
Local Institution, Box Hill
Local Institution, Greenslopes
Local Institution, Woolloongabba
Local Institution, Wellington
Universitaetsspital Zuerich, Zurich
Local Institution, Santiago Compostela
Local Institution, Milan
Elbe Klinikum Buxtehude, Buxtehude
Local Institution, Jaén
Local Institution, Madrid
Local Institution, Málaga
Local Institution, Hanover
Mount Sinai Comprehensive Cancer Center, Miami Beach
Georg August Universitaet Goettingen, Göttingen
Local Institution, Saint-Etienne
Local Institution, Essen
Local Institution, Valencia
Azienda Ospedaliera Universitaria Senese, Siena
Interbalkan European Medical Center, Thessaloniki
University Of Chicago, Chicago
Local Institution, Heidelberg
Local Institution, Tübingen
University Of Colorado, Aurora
Istituto Nazionale Tumori Fondazione Pascale, Napoli
Local Institution, München
Angeles Clinic and Research Institute, Los Angeles
Local Institution, Boulogne-Billancourt
Local Institution, Villejuif
Oregon Health & Science University, Portland
Local Institution, Seattle
Local Institution, Chuo-ku
Local Institution, Osaka
Local Institution, Okayama
Local Institution, Niigata
Local Institution, Sendai
Local Institution, Montreal
Local Institution, Québec
Klinika onkologie a radioterapie, Hradec Králové
Dermatovenerologicka klinika 3. LF UK a FNKV, Prague
Dermatovenerologicka klinika VFN a 1. LF UK, Prague
Universitaetsklinikum Carl Gustav Carus, Dresden
SRH Wald-Kliniken Gera GmbH, Gera
Local Institution, Dooradoyle
Local Institution, Christchurch
Local Institution, Amsterdam
Local Institution, Groningen
Local Institution, Nijmegen
Local Institution, Rotterdam
Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow, Warsaw
Local Institution, Barcelona
Local Institution, London
Local Institution, London
Local Institution, Belfast
Local Institution, Cambridge
Local Institution, Cottingham
Local Institution, Manchester
Local Institution, Tauton
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY